David S. Siegel

3 ta ish

Dana-Farber Cancer Institute

1. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

   Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25

   Maqola20217 iqtibos

   ABIABI:AkademIndex/2026.other.296878

2. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

   Noopur Raje, Jesús G. Berdeja, Yi Lin +20

   MaqolaOAOchiq kirish20195 iqtibos

   ABIABI:AkademIndex/2026.other.082848

3. Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma

   Larysa Sanchez, Yucai Wang, David S. Siegel +1

   Sharh maqolaOAOchiq kirish20162 iqtibos

   ABIABI:AkademIndex/2026.other.082809